Walmart has given a major reason to gadget lovers to rejoice. Starting November 01, the retail giant is offering Apple’s 16 GB Wi-Fi only iPad Mini 2 at $199, significantly lower than $269.
The offer has been introduced as part of the “Hot Holiday Rollbacks” by Walmart. Apple Wi-Fi only iPad mini 2 specifications include:
- 7.9-inch Apple iPad with retina display
- A7 chip with M7 motion coprocessor
- Built-in Wi-Fi (802.11a/b/g/n) with MIMO support
- Up to 10 hours of battery life
- 5MP iSight camera with 1080p HD video recording, FaceTime HD camera
- iOS 7 and iCloud
- Cellular data service on Wi-Fi + cellular models (sold separately)
- Available in space gray or silver
Macrumors says that Walmart will be selling the 16GB iPad mini 2 for $199 for around 90 days, the standard amount of time Walmart price rollbacks generally last.


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



